Top Castrate Resistant Prostate Cancer Therapeutics Companies, Leaders & Major Players

This list of the top companies of Castrate Resistant Prostate Cancer Therapeutics is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Castrate Resistant Prostate Cancer Therapeutics sector.

Top Castrate Resistant Prostate Cancer Therapeutics Companies

  1. Sanofi

  2. Johnson & Johnson

  3. Bayer

  4. Dendreon Pharmaceuticals

  5. Pfizer

*Disclaimer: Top companies sorted in no particular order

Castrate Resistant Prostate Cancer Therapeutics Market Major Players

Castrate Resistant Prostate Cancer Therapeutics - Competitive Concentration

Castrate Resistant Prostate Cancer Therapeutics Market Concentration

List of Castrate Resistant Prostate Cancer Therapeutics Companies

  • Johnson & Johnson

  • Pfizer Inc / Astellas Pharma

  • Bayer

  • Sanofi

  • AstraZeneca

  • Novartis AG (AAA)

  • Amgen

  • Merck

  • Roche Holding

  • Myovant Sciences

  • Kintor Pharmaceutical

  • Seagen Inc

  • BeiGene

  • Clovis Oncology

  • Nanjing Chia-Tai Tianqing

  • Aragon Pharmaceut. Inc

  • GlaxoSmithKline

Get more insights on Castrate Resistant Prostate Cancer Therapeutics industry from our comprehensive report

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds